Federally licensed Montreal-based psychedelic biotechnology developer and manufacturer of cultivated and synthetic entheogens (psilocybin, mescaline, DMT and monoamine oxidase inhibitors) that commercializes medicines to treat mental illness and addiction and produces finished drug products for pharmaceutical partners.